HomeInvestingEarningsARGX, GTHX, MRSN: How Biotech Can Be A Defensive Play
ARGX, GTHX, MRSN: How Biotech Can Be A Defensive Play

This is a good time to look at biotech since it tends to hold up relatively well during bear markets and recessions, says Andrew Wang. He and David Nierengarten discuss the biotech sector. They talk about how Wedbush has outperform ratings for ARGX, GTHX, MRSN, TSVT, and SRRK. They also go over why the biotech sector could be a defensive play. Next, they mention investing strategies for biotech stocks. Tune in to find out more about the stock market today.

Trading 360

13 Jan 2023

ON AIR
3:30 am
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
ON AIR
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US